Elevated Alanine Transaminase (ALT) Levels Management

Initial Evaluation and Diagnostic Approach

The management of elevated ALT should focus on identifying and treating the underlying cause, as ALT elevation is a marker of liver cell injury rather than a disease itself, according to the American Gastroenterological Association 1
Elevated ALT levels should be evaluated with consideration of the degree of elevation (mild, moderate, or severe) 2
Elevated ALT levels should be evaluated with consideration of the duration (acute vs. chronic) 3
A complete liver panel (ALT, AST, alkaline phosphatase, bilirubin, albumin) is recommended for diagnostic workup 1, 3
Viral hepatitis serologies, including Hepatitis B and C, should be performed as part of the diagnostic workup 1, 3

For chronic hepatitis B, treatment is recommended if ALT is >2 times normal or moderate/severe hepatitis on biopsy, and HBV DNA >20,000 IU/ml, as per the American Association for the Study of Liver Diseases 3
For HBeAg-negative chronic hepatitis B, treatment is recommended if serum HBV DNA >20,000 IU/ml and elevated ALT >2 times normal 3
For valoctocogene roxaparvovec gene therapy-related ALT elevation, prednisone 60 mg/day for ≥2 weeks is recommended for ALT ≥1.5× above baseline or above ULN 4, 6

For patients with chronic hepatitis B on treatment, monitor liver panel every 12 weeks and check HBV DNA levels every 12-24 weeks, as recommended by the American Association for the Study of Liver Diseases 3
The upper limit of normal for ALT should be considered lower than traditional laboratory values, with 30 IU/mL for men and 19 IU/mL for women, according to the American Gastroenterological Association 1, 7